Please login to the form below

Not currently logged in
Email:
Password:

autism

This page shows the latest autism news and features for those working in and with pharma, biotech and healthcare.

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals

The first of the new products is RAD Neurim Pharma’s Slenyto, a small-tablet formulation of the hormone melatonin for the treatment of insomnia in children and adolescents with autism

Latest news

  • Roche’s autism drug scores FDA breakthrough status Roche’s autism drug scores FDA breakthrough status

    A drug that may improve social interaction and communication in people with autism spectrum disorder (ASD) has been granted Breakthrough Therapy Designation by the US Food and Drug Administration. ... Reported at the International Congress for Autism

  • Judge forces NHS England rethink on Kuvan Judge forces NHS England rethink on Kuvan

    The unnamed seven-year-old boy also has severe autism, which makes adhering to the dietary restrictions usually deployed to manage PKU - and prevent the serious brain damage that can be ... Kuvan was once tested as a treatment for autism itself, but

  • GSK asthma app wins healthcare technology award GSK asthma app wins healthcare technology award

    Its fellow winners at the Awards included software that turns physiotherapy into video games and a collection of clothes that heighten or mute senses to help people affected by autism.

  • Celgene plans real-world study using Apple's ResearchKit Celgene plans real-world study using Apple's ResearchKit

    The technology is being used in academic studies in autism, epilepsy and melanoma, and earlier this year GlaxoSmithKline launched the first industry trial powered by ResearchKit for an arthritis study. .

  • GSK launches first pharma trial powered by Apple's ResearchKit GSK launches first pharma trial powered by Apple's ResearchKit

    Meanwhile, ResearchKit, which helps users to gather data more frequently and more accurately from study participants using iPhone apps, has already been used in studies for autism, epilepsy and melanoma.

More from news
Approximately 2 fully matching, plus 30 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GK Strategy

GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics